AKT1 and thyroid gland carcinoma: LPAR3 was reported as a part of the ZEB1-AS1/miR-133a-3p/LPAR3/EGFR axis that promotes thyroid cancer progression by regulating PI3K/Akt/mTOR signaling [41].